Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile


Gilead Sciences, Inc. 

333 Lakeside Drive

Foster City  California  94404  U.S.A.
Phone: 800-GILEAD-5 or 650-574-3000 Fax: 650-522-5800


Gilead Sciences is a biopharmaceutical company that discovers, develops, and commercializes innovative therapeutics in areas of unmet medical need.The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia.

 Key Statistics

Ownership: Public

Web Site: Gilead Sciences, Inc.
Employees: 4,000
Symbol: GILD


 Company News
Gilead Sciences, Inc. (GILD) Popular Amongst Latest 13F Filers 7/31/2014 6:56:16 AM
Theraclone Sciences, Inc. Announces Exclusive Agreement With Gilead Sciences, Inc. (GILD) For Broadly Neutralizing HIV Antibodies 7/30/2014 9:34:50 AM
Gilead Sciences, Inc. (GILD) Allows China/Indian Pharmas To Make Generic Version Of Novel HIV Drug 7/30/2014 8:49:04 AM
Politicizing Gilead Sciences, Inc. (GILD)'s R&D Solvadi Costs Is A Reckless And Dangerous Misadventure 7/28/2014 6:11:16 AM
European CHMP Adopts Positive Opinion For Gilead Sciences, Inc. (GILD)’s Zydelig® (Idelalisib) For The Treatment Of Chronic Lymphocytic Leukemia And Follicular Lymphoma 7/25/2014 9:06:11 AM
Gilead Sciences, Inc. (GILD) Announces Second Quarter 2014 Financial Results 7/24/2014 12:59:13 PM
Hepatitis B Drug Rockets Gilead Sciences, Inc. (GILD) Into The Big Leagues 7/24/2014 11:14:32 AM
4 Ways Gilead Sciences, Inc. (GILD)’s Earnings Will Impact Every American 7/24/2014 6:24:51 AM
Gilead Sciences, Inc. (GILD), Medicines Patent Pool Strike Deal: New Opportunity For Indian Drugmakers 7/24/2014 6:15:06 AM
FDA Approves Gilead Sciences, Inc. (GILD)'s Zydelig® (idelalisib) For Relapsed Chronic Lymphocytic Leukemia, Follicular Lymphoma And Small Lymphocytic Lymphoma 7/23/2014 10:30:32 AM